Vivo Capital’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Vivo Capital’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-132,574	Closed	-$3.05M	–	65
2021 Q3	$3.05M	Hold	132,574	–	–	0.14%	55
2021 Q2	$5.82M	Hold	132,574	–	–	0.25%	51
2021 Q1	$9.63M	Hold	132,574	–	–	0.34%	41
2020 Q4	$5.73M	Hold	132,574	–	–	0.26%	48
2020 Q3	$5.45M	Hold	132,574	–	–	0.31%	51
2020 Q2	$7.95M	Sell	132,574 -30,149	-19%	-$2.76M	0.57%	38
2020 Q1	$12.3M	Buy	+162,723	New	+$18.7M	1.11%	24
2019 Q3	–	Sell	-131,208	Closed	-$18.4M	–	35
2019 Q2	$18.4M	Buy	131,208 +83,047	+172%	+$14.6M	1.72%	18
2019 Q1	$8.61M	Sell	48,161 -33,028	-41%	-$4.96M	0.86%	31
2018 Q4	$12.8M	Buy	+81,189	New	+$12.1M	1.63%	17

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vivo Capital's ORTX Position: Q4 2021 in Review

Vivo Capital sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 132,574 shares — an estimated $3.05M sold.

Vivo Capital first reported a position in ORTX in Q4 2018 and held it in 10 quarters. The position peaked at $18.4M in Q2 2019. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

Vivo Capital reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Vivo Capital sold 132,574 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $3.05M.
Vivo Capital first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
Vivo Capital's Orchard Therapeutics plc American Depositary Shares position peaked at $18.4M in Q2 2019.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Vivo Capital's 13F filing for Q4 2021, filed 11 Feb 2022.